drugset / Trial / NCT07156201
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years
RandomizedParallel-groupTriple-blindTreatment
Summary
This first in human trial will evaluate the safety, tolerability, and pharmacokinetics of single ascending doses, multiple ascending doses, and fed and fasted doses of ABS-1230 given orally compared with placebo in adult healthy participants.
Timeline
- Start
- 2025-08-28
- Primary completion
- 2026-03
- Completion
- 2026-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABS-1230 | Unknown | — | Oral |
| Background | Omeprazole | Other / unclassified | — | — |
Indications
No indication recorded.